TDP-43 based biomarker development in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a devastating neurodegenerative disease which is clinically and aetiologically heterogenous. However, TDP-43 neuropathology is a unifying hallmark found in 97% of ALS cases. Understanding the common pathological pathways downstream of TDP-43 dysregulation is essentia...
Autor principal: | Feneberg, E |
---|---|
Altres autors: | Turner, M |
Format: | Thesis |
Idioma: | English |
Publicat: |
2019
|
Matèries: |
Ítems similars
-
Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
per: Rachel H. Tan, et al.
Publicat: (2023-11-01) -
Advancements in TDP-43 research: Towards biomarkers and therapeutic targets for amyotrophic lateral sclerosis
per: Yuhan Wu, et al.
Publicat: (2025-03-01) -
The role of TDP-43 protein in amyotrophic lateral sclerosis
per: Piotr Włodarczyk, et al.
Publicat: (2022-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
per: Joanna Iłżecka
Publicat: (2017-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
per: Joanna Iłżecka
Publicat: (2017-12-01)